ZHONGCHAO INC-CLASS A (ZCMD)
KYG9897X1152 - Common Stock
Overall ZCMD gets a fundamental rating of 3 out of 10. We evaluated ZCMD against 65 industry peers in the Diversified Consumer Services industry. While ZCMD has a great health rating, there are worries on its profitability. ZCMD does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
ZCMD had negative earnings in the past year.
In the past year ZCMD has reported a negative cash flow from operations.
Of the past 5 years ZCMD 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: ZCMD reported negative operating cash flow in multiple years.
1.2 Ratios
ZCMD has a Return On Assets of -7.61%. This is in the lower half of the industry: ZCMD underperforms 60.94% of its industry peers.
ZCMD has a Return On Equity (-9.82%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.61% | ||
| ROE | -9.82% | ||
| ROIC | N/A |
ROA(3y)1.95%
ROA(5y)10.04%
ROE(3y)1.64%
ROE(5y)11.54%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 44.92%, ZCMD is not doing good in the industry: 60.94% of the companies in the same industry are doing better.
ZCMD's Gross Margin has declined in the last couple of years.
ZCMD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.92% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.21%
GM growth 5Y-5.48%
2. Health
2.1 Basic Checks
ZCMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ZCMD has been increased compared to 1 year ago.
Compared to 5 years ago, ZCMD has more shares outstanding
ZCMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
ZCMD has an Altman-Z score of 1.16. This is a bad value and indicates that ZCMD is not financially healthy and even has some risk of bankruptcy.
ZCMD has a Altman-Z score (1.16) which is in line with its industry peers.
There is no outstanding debt for ZCMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.16 |
ROIC/WACCN/A
WACC7.54%
2.3 Liquidity
ZCMD has a Current Ratio of 5.44. This indicates that ZCMD is financially healthy and has no problem in meeting its short term obligations.
ZCMD has a Current ratio of 5.44. This is amongst the best in the industry. ZCMD outperforms 93.75% of its industry peers.
ZCMD has a Quick Ratio of 5.40. This indicates that ZCMD is financially healthy and has no problem in meeting its short term obligations.
ZCMD's Quick ratio of 5.40 is amongst the best of the industry. ZCMD outperforms 93.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.44 | ||
| Quick Ratio | 5.4 |
3. Growth
3.1 Past
The earnings per share for ZCMD have decreased strongly by -1300.00% in the last year.
The Revenue for ZCMD has decreased by -13.13% in the past year. This is quite bad
The Revenue has been growing slightly by 7.58% on average over the past years.
EPS 1Y (TTM)-1300%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-300%
Revenue 1Y (TTM)-13.13%
Revenue growth 3Y-1.66%
Revenue growth 5Y7.58%
Revenue growth Q2Q-10.68%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ZCMD. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
ZCMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ZHONGCHAO INC-CLASS A
NASDAQ:ZCMD (4/22/2024, 7:00:03 PM)
After market: 1.53 -0.06 (-3.77%)1.59
-0.35 (-18.04%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.93M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.61% | ||
| ROE | -9.82% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.92% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 5.44 | ||
| Quick Ratio | 5.4 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-1300%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-13.13%
Revenue growth 3Y-1.66%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y